Jason Haas Ligand Pharmaceuticals Inc (LGND) insider trading activity

LGND Quotes by TradingView

Jason Haas is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 6,606 shares of LGND, which is worth approximately $932,238. The most recent transaction as insider was on Jun 06, 2025, when has been sold 1,209 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.61K
22.4% 3M change
22.4% 12M change
Total Value Held $932,238

Jason Haas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2025
BUY
Grant, award, or other acquisition
-
1,209 Added 15.47%
6,606 Common Stock
Jun 14 2024
BUY
Grant, award, or other acquisition
-
1,252 Added 18.83%
5,397 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 21.6%
4,145 Common Stock
Jun 29 2022
BUY
Grant, award, or other acquisition
-
1,750 Added 50.0%
1,750 Common Stock

Also insider at

SYRS
Syros Pharmaceuticals, Inc. Healthcare
Chief Financial Officer
JH

Jason Haas

Director
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LGND